United States v. Keith Stanford Irick

497 F.2d 1369
CourtCourt of Appeals for the Fifth Circuit
DecidedOctober 17, 1974
Docket1369
StatusPublished
Cited by13 cases

This text of 497 F.2d 1369 (United States v. Keith Stanford Irick) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Keith Stanford Irick, 497 F.2d 1369 (5th Cir. 1974).

Opinion

AINSWORTH, Circuit Judge:

The question presented for decision is whether an indictment charging assault of an officer of the Drug Enforcement Administration is fatally defective because the pertinent statutes, though they encompass assaults on “any officer or employee of the Bureau of Narcotics and Dangerous Drugs,” do not specifically refer to the Drug Enforcement Administration, the successor in the Department of Justice to the Bureau of Narcotics and Dangerous Drugs.

Defendants Keith Stanford Irick, David Paul Kay, Richard Neil Myers, and Joseph Edwin Peel were named in an indictment which charged that on or about August 27, 1973, they “wilfully and by use of a deadly and dangerous weapon, that is, a bayonet, did forcibly assault, resist, oppose, impede, intimidate, and interfere with ... a Special Agent of the Drug Enforcement Administration, United States Department of Justice while [he] was engaged in the performance of his official duties.” The indictment charged violation of 18 U.S.C. §§ 111 and 2. 1

Section 111 of Title 18, United States Code, prohibits, inter alia, the forcible assault, intimidation, or interference with “any person designated in [18 U.S.C. § 1114] while engaged in or on account of the performance of his official duties . . . ,” 2 Section 1114 designates several categories of federal officers and employees. Among the categories designated is the Bureau of Narcotics and Dangerous Drugs, the predecessor in the Department of Justice of the Drug Enforcement Administration. 3

The Bureau of Narcotics and Dangerous Drugs was established by Reorganization Plan No. 2 of 1973. 1973 U.S.Code Cong. & Admin.News 3554. The plan became effective without congressional action on July 1, 1973, as provided by 5 U.S.C. § 906(a); and on July 10, 1973, pursuant to Executive Order *1371 11727, dated July 6, 1973, the Attorney General transferred the functions of the Bureau of Narcotics and Dangerous Drugs to the Drug Enforcement Administration by amending the Code of Federal Regulations, 38 Fed.Reg. 18380. 4 Thus, as the district court found, “the Drug Enforcement Administration, its officers and employees, are the successors to the Bureau of Narcotics and Dangerous Drugs, its officers and employees in function and authority.” Section 1114, however, was not amended to reflect this changeover from the Bureau of Narcotics and Dangerous Drugs to the Drug Enforcement Administration.

In the court below, each of the defendants moved to dismiss the indictment for failure to charge an offense on the ground that agents of the Drug Enforcement Administration are not within the categories designated under 18 U.S.C. § 1114 and, thus, assaults on such agents are not encompassed by 18 U.S.C. § 111. Notwithstanding its finding that the Drug Enforcement Administration is the successor to the Bureau of Narcotics and Dangerous Drugs, the district court held that section 111 does not apply to assaults on Drug Enforcement Administration agents because Congress failed to amend section 1114 to substitute the Drug Enforcement Administration for the Bureau of Narcotics and Dangerous Drugs. Concluding that section 1114 “applies only to those departments, agencies, and bureaus specifically named therein,” the court granted defendants’ motions and ordered the indictment dismissed. The Government appeals pursuant to 18 U.S.C. § 3731. 5

The district court’s memorandum and order concluding that the indictment should be dismissed omits reference to 5 U.S.C. § 907(a), enacted September 6, 1966. 6 Section 907(a), which provides for continuity of status and function in connection with executive reorganizations, controls the issues presented. It reads in full:

§ 907. Effect on other laws, pending legal proceedings, and unexpended appropriations.
(a) A statute enacted, and a regulation or other action made, prescribed, issued, granted, or performed in respect of or by an agency or function affected by a reorganization under this chapter, before the effective date of the reorganization, has, except to the extent rescinded, modified, superseded, or made inapplicable by or under authority of law or by the abolition of a function, the same effect as if the reorganization had not been made. However, if the statute, regulation, or other action has vested the *1372 functions in the agency from which it is removed under the reorganization plan, the function insofar as it is to be exercised after the plan becomes effective, shall be deemed as vested in the agency under which the function is placed by the plan. (Emphasis added.)'

The section’s legislative history reflects the clear meaning of the statutory language, that is, the desire of Congress not to leave a hiatus in existing law when a reorganization has taken place. A House Report on the 1949 Reorganization Act, the predecessor of the 1966 reorganization statute, explains that section 907 /‘contains saving provisions with respect to the status, after a reorganization, of statutory provisions, regulations, and other actions, and suits and other proceedings, having a relation to any agency or function affected by such reorganization.” H.R.Rep. No. 23, 81st Cong., 1st Sess., 1949 U.S.Code Cong. Serv. 1391. In addition, a House Report commenting on a similar saving clause in the original Reorganization Act of 1939 noted that the saving clause “provides for the survival of laws in connection with reorganizations.” H.R.Rep. No. 120, 76th Cong., 1st Sess. 6 (1939).

Basically, when a reorganization takes place, section 907(a) continues in effect laws existing prior to the reorganization. Any statute relating to an agency and enacted before the effective date of the reorganization of that agency has the same effect as if there had been no reorganization. Thus, special agents of the Drug Enforcement Administration fall within the ambit of section 111, by virtue of the provisions of section 1114, in the same manner as did the special agents of the Bureau of Narcotics and Dangerous Drugs.

On appeal, defendants pose four basic arguments as militating against the application of section 907(a) to their situation.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Damon Depreece Garrett
172 F. App'x 295 (Eleventh Circuit, 2006)
Lucas v. United States
443 F. Supp. 539 (District of Columbia, 1977)
United States v. Michael Lance Carvin
555 F.2d 1303 (Fifth Circuit, 1977)
United States v. James Hillsman and Clinton Bush
522 F.2d 454 (Seventh Circuit, 1975)
Peel v. United States
420 U.S. 945 (Supreme Court, 1975)
United States v. Irick
503 F.2d 568 (Fifth Circuit, 1974)

Cite This Page — Counsel Stack

Bluebook (online)
497 F.2d 1369, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-keith-stanford-irick-ca5-1974.